XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plans and Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity for the period ended March 31, 2023 is as follows (in thousands, expect share and per share data and years):

 

 

 

Options

 

 

Weighted-Average
Exercise
Price per Share

 

 

Weighted-Average
Remaining
Contractual Term

 

 

Aggregate
Intrinsic Value

 

Outstanding at December 31, 2022

 

 

5,890,869

 

 

$

7.91

 

 

 

8.8

 

 

$

13,492

 

Granted

 

 

541,300

 

 

$

8.55

 

 

 

 

 

 

 

Exercised

 

 

(97,227

)

 

$

1.68

 

 

 

 

 

 

 

Cancelled

 

 

(208,849

)

 

$

11.68

 

 

 

 

 

 

 

Outstanding at March 31, 2023

 

 

6,126,093

 

 

$

7.94

 

 

 

8.5

 

 

$

55,897

 

Exercisable at March 31, 2023

 

 

1,975,304

 

 

$

7.06

 

 

 

7.5

 

 

$

20,377

 

Vested and expected to vest as of March 31, 2023

 

 

6,126,093

 

 

$

7.94

 

 

 

8.5

 

 

$

55,897

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The fair value of stock options was estimated using the following assumptions (excluding option modifications):

 

 

 

Three Months Ended
March 31,

 

 

 

2023

 

2022

 

Stock Options:

 

 

 

 

 

Stock price

 

$7.07 - 13.20

 

$10.96 - 12.31

 

Risk-free rate of interest

 

3.5 - 4.2%

 

1.6 - 2.0%

 

Expected term (years)

 

6.0 - 6.1

 

6.0 - 6.1

 

Expected stock price volatility

 

89.2 - 89.7%

 

86.4 - 90.4%

 

Dividend yield

 

 

 

Schedule of Stock-based Compensation Expense

Stock-based compensation expense recognized for all equity awards has been reported in the statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2023

 

 

2022

 

Research and development expense

 

$

1,460

 

 

$

1,478

 

General and administrative expense

 

 

973

 

 

 

2,494

 

Total

 

$

2,433

 

 

$

3,972

 

Schedule of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consisted of the following:

 

 

 

March 31,
2023

 

 

December 31,
2022

 

Common stock options granted and outstanding

 

 

6,126,093

 

 

 

5,890,869

 

Shares available for future issuance under the 2021
   Incentive Award Plan

 

 

6,138,644

 

 

 

4,339,373

 

Shares available for future issuance under the
   2021 Employee Stock Purchase Plan

 

 

1,153,344

 

 

 

759,442

 

Total common stock reserved for future issuance

 

 

13,418,081

 

 

 

10,989,684

 

Schedule of Share-Based Compensation, Employee Stock Purchase Plan The fair value of shares purchased under the ESPP was estimated using the following assumptions:

 

 

 

Three Months Ended
March 31,

 

 

2023

 

2022

Stock Options:

 

 

 

 

Stock price

 

$14.77

 

$11.03

Risk-free rate of interest

 

4.1 - 4.9%

 

0.9 - 2.0%

Expected term (years)

 

0.5 - 2.0

 

0.5 - 2.0

Expected stock price volatility

 

99.2 - 122.5%

 

80.7 - 89.8%

Dividend yield